BMA
OGN icon

Brooks Moore & Associates’s Organon & Co OGN Stock Holding History

Brooks Moore & Associates’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-31,959
Closed -$461K – 92
2023
Q4 		$461K Sell
31,959
-21,250
-40% -$289K 0.32% 60
2023
Q3 		$924K Buy
53,209
+2,025
+4% +$42.2K 0.7% 42
2023
Q2 		$1.06M Buy
51,184
+10,535
+26% +$229K 0.75% 42
2023
Q1 		$956K Buy
40,649
+13,834
+52% +$371K 0.69% 44
2022
Q4 		$749K Buy
+26,815
New +$686K 0.55% 48
2021
Q4 		– Sell
-21,813
Closed -$715K – 100
2021
Q3 		$715K Buy
21,813
+300
+1% +$9.6K 0.47% 57
2021
Q2 		$651K Buy
+21,513
New +$708K 0.42% 63

Other funds holding OGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $2.98B AUM 22.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Brooks Moore & Associates's OGN Position: Q1 2024 in Review

Brooks Moore & Associates sold out of Organon & Co (OGN) in Q1 2024, closing a stake of 31,959 shares — an estimated $461K sold.

Brooks Moore & Associates first reported a position in OGN in Q2 2021 and held it in 7 quarters. The position peaked at $1.06M in Q2 2023. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

  • Brooks Moore & Associates reported no remaining Organon & Co position as of Q1 2024 after selling out during the quarter.
  • Brooks Moore & Associates sold 31,959 Organon & Co shares in Q1 2024, an estimated $461K.
  • Brooks Moore & Associates first reported a position in Organon & Co in Q2 2021 and held it in 7 quarters.
  • Brooks Moore & Associates's Organon & Co position peaked at $1.06M in Q2 2023.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on Brooks Moore & Associates's 13F filing for Q1 2024, filed 14 May 2024.